E-LIB Suche - Ergebnisse für: Granito, A.

1

Sorafenib as a second-line treatment after failure of atezo..:

Tovoli, F. ; Boe, M. ; Vivaldi, C....
Digestive and Liver Disease. 56 (2024) - p. S79 , 2024

Link: https://doi.org/10.1016/..

2

Aetiology of hepatocellular carcinoma and response to immun..:

Tovoli, F. ; Chen, R. ; Vivaldi, C....
Digestive and Liver Disease. 56 (2024) - p. S92-S93 , 2024

Link: https://doi.org/10.1016/..

3

Management of portal hypertension in patients receiving ate..:

Tovoli, F. ; Franceschini, E. ; Vivaldi, C....
Digestive and Liver Disease. 56 (2024) - p. S87 , 2024

Link: https://doi.org/10.1016/..

4

Comparative analysis of subclassification models in patient..:

Ielasi, L. ; Stefanini, B. ; Conti, F....
Digestive and Liver Disease. 56 (2024) - p. S85 , 2024

Link: https://doi.org/10.1016/..

5

Efficacy and safety of atezolizumab/bevacizumab for hepatoc..:

Tovoli, F. ; Vivaldi, C. ; Federico, P....
Digestive and Liver Disease. 56 (2024) - p. S85-S86 , 2024

Link: https://doi.org/10.1016/..

6

Clinical impact of relative dose intensity of cabozantinib ..:

Tovoli, F. ; Dadduzio, V. ; De Lorenzo, S....
Digestive and Liver Disease. 55 (2023) - p. S224-S225 , 2023

Link: https://doi.org/10.1016/..

7

OC.12.4 PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR ..:

Sacco, R. ; Ciruolo, M. ; Paolillo, R....
Digestive and Liver Disease. 55 (2023) - p. S119-S120 , 2023

Link: https://doi.org/10.1016/..

8

Prognostic impact of metastatic site in patients receiving ..:

Ielasi, L. ; Tovoli, F. ; Stefanini, B....
Digestive and Liver Disease. 55 (2023) - p. S42 , 2023

Link: https://doi.org/10.1016/..

9

Prognostic impact of previous intraarterial treatment in pa..:

Stefanini, B. ; Ielasi, L. ; Pressiani, T....
Digestive and Liver Disease. 55 (2023) - p. S54-S55 , 2023

Link: https://doi.org/10.1016/..

10

Sequential systemic treatments for hepatocellular carcinoma..:

Tovoli, F. ; Tonnini, M. ; Mandolesi, R....
Digestive and Liver Disease. 55 (2023) - p. S211-S212 , 2023

Link: https://doi.org/10.1016/..

11

Outcomes of Sorafenib and Metronomic Capecitabine in Child-..:

Stefanini, B. ; Bucci, L. ; Santi, V....
Digestive and Liver Disease. 55 (2023) - p. S222-S223 , 2023

Link: https://doi.org/10.1016/..

12

Prognostic impact of sarcopenia on patients with advanced h..:

Lani, L. ; Reggidori, N. ; Renzulli, M....
Digestive and Liver Disease. 54 (2022) - p. S29 , 2022

Link: https://doi.org/10.1016/..

13

T.08.10 IMPACT OF SARCOPENIA ON SURVIVAL OF PATIENTS AFFECT..:

Reggidori, N. ; Lani, L. ; Renzulli, M....
Digestive and Liver Disease. 54 (2022) - p. S151 , 2022

Link: https://doi.org/10.1016/..

14

Real-life clinical data of cabozantinib for unresectable he..:

Tovoli, F. ; Dadduzio, V. ; De Lorenzo, S....
Digestive and Liver Disease. 53 (2021) - p. S10 , 2021

Link: https://doi.org/10.1016/..

15

Pattern of progression of intrahepatic cholangiocarcinoma i..:

Tovoli, F. ; Garajovà, I. ; Iavarone, M....
Digestive and Liver Disease. 53 (2021) - p. S19 , 2021

Link: https://doi.org/10.1016/..